Whitepaper: Collaboration of Venture Valuation and Ferring Pharmaceuticals

Switzerland, March 2019: Venture Valuation has been working with Ferring Pharmaceutical supporting the company with external, third-party product/asset valuations of potential in-licensing opportunities. After Ferring had identified a specific opportunity and deemed interesting to move it forward in the internal evaluation process, Venture Valuation was mandated to review the product/opportunity from an external point of view. Ferring are looking for collaborations within women’s health, specifically treatments regarding fertility, reproductive cycle, pregnancy, and childbirth.

Download the whitepaper

Would you like to be notified about new articles, reports and other valuable content published by Venture Valuation?